350 Afleveringen

  1. Episode 109: Scott Gottlieb on Covid-19 treatments, reopening America, and going on TV every day

    Gepubliceerd: 30-4-2020
  2. Episode 108: A vaccine official is ousted, how to use ventilators, & the fate of the JPM conference

    Gepubliceerd: 23-4-2020
  3. Episode 107: Covid-19 disrupts D.C., how not to be boring on Zoom, and the trial of Elizabeth Holmes

    Gepubliceerd: 16-4-2020
  4. Episode 106: Privacy in a pandemic, biopharma's big opportunity, and Shkreli's plea for a break

    Gepubliceerd: 9-4-2020
  5. Episode 105: Pandemic exit strategies, how the outbreak affects patients, and Ken Burns takes on DNA

    Gepubliceerd: 2-4-2020
  6. Fauci's star turn, the latest on coronavirus, and an under-the-radar Alzheimer's drug

    Gepubliceerd: 26-3-2020
  7. Episode 103: Trump's coronavirus pivot, life inside the ICU & drug development in a pandemic

    Gepubliceerd: 19-3-2020
  8. Episode 102: Voices from the coronavirus pandemic, in Italy, New York, and the high seas

    Gepubliceerd: 12-3-2020
  9. Episode 101: Pharma’s response to coronavirus, Google's appetite for health data, & biotech in China

    Gepubliceerd: 5-3-2020
  10. Episode 100: Wall Street's coronavirus freakout, clinical trial difficulties, and a look back

    Gepubliceerd: 27-2-2020
  11. Episode 99: Genetic medicine w/ Ethan Weiss, drug industry infighting, & a microbiome review

    Gepubliceerd: 20-2-2020
  12. Episode 98: Les Funtleyder on biotech investing; the Zolgensma lottery & billionaire philanthropy

    Gepubliceerd: 13-2-2020
  13. Episode 97: Fake outbreak news, treating coronavirus, and biotech's Mount Rushmore

    Gepubliceerd: 6-2-2020
  14. Episode 96: A chemist breaks bad, the latest from Wuhan, and pharma's slow Bern

    Gepubliceerd: 30-1-2020
  15. Episode 95: The latest on the China virus, Sarepta's ongoing FDA saga, and biotech at Davos

    Gepubliceerd: 23-1-2020
  16. Episode 94: EQRx's Alexis Borisy, Stephen Buck on his website for cancer patients, and a JPM recap

    Gepubliceerd: 16-1-2020
  17. Episode 93: Josiah Zayner on getting canceled, good news in cancer, an Ebola vaccine saga

    Gepubliceerd: 9-1-2020
  18. Episode 92: The decade in breakthroughs, the year in bad CEOs, and the viruses that cure disease

    Gepubliceerd: 19-12-2019
  19. Episode 91: CAR-T's future, an alarming cancer trend & Chris Garabedian on Sarepta's FDA legacy

    Gepubliceerd: 12-12-2019
  20. Episode 90: Biogen's big reveal, hot takes on Alzheimer's, & the science of one-eyed sheep

    Gepubliceerd: 5-12-2019

13 / 18

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

Visit the podcast's native language site